Banco Comercial Português, SA informs about Q1 2022 Report and Accounts
Banco Comercial Português, SA informs about Q1 2022 Report and AccountsAttachment3M2022BCPRA
Month: May 2022
PRESS RELEASE: BIGBEN: RESULTS IN LINE WITH EXPECTATIONS
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Bigben
Press release
Lesquin, 30 May 2022 18:00hrs
RESULTS IN LINE WITH EXPECTATIONS:SALES : 275.7 M€
CURRENT OPERATING INCOME : 21.0 M€AMBITIOUS TARGETS FOR 2022-23 DRIVEN BY THE GAMING MOMENTUMSALES OF 400 M€
CURRENT OPERATING INCOME EXCEEDING 55 M€BIGBEN INTERACTIVE (ISIN FR0000074072) today releases its audited consolidated results for FY 2021/22 (from April 1, 2021 to March 31, 2022) as approved by its Board of directors on 30 May 2022.Consolidated in M€ IFRS
2021-22
2020-21
ChangeSales
275.7
292.8
-5.8%Gross Margin In % of sales
EBITDA In % of sales109.239.6%
50.318.2%121.841.6%
67.623.1%
-10.3%
-25.6%Current Operating Income courant In % of sales
Non recurrent items
21.07.6%
(7.6)
36.212.4%
(6.4)-42.0%Operating IncomeIn % of sales
...
PRESS RELEASE: NACON: 2021-22 ANNUAL SALES IN LINE WITH EXPECTATIONS
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Nacon
Press release
Lesquin, 30 May 2022, 18:00hrs
2021-22 ANNUAL SALES IN LINE WITH EXPECTATIONS155.9 M€ SALES
19.0 M€ CURRENT OPERATING INCOMESTRONG GROWTH MOMENTUM EXPECTED IN 2022-23:SALES OVER 250 M€
CURRENT OPERATING MARGIN EXCEEDING 50 M€ NACON (ISIN FR0013482791) today releases its audited consolidated results for FY 2021/22 (from April 1, 2021 to March 31, 2022) as approved by its Board of directors on 30 May 2022.Consolidated in M€ IFRS
2021–2022
2020–2021
ChangeSales
155.9
177.8
-12.3%Gross MarginIn % of sales
EBITDAIn % of sales77.849.9%
44.628.6%93.552.6%
60.333.9%
-16.7%
-26.0%Current Operating IncomeIn % of sales
Non recurrent items
19.012.2%
(5.7)
32.518.3%
(5.1)-41.6%Operating IncomeIn % of sales
13.38.6%
27.515.4%
-51.4%Financial...
Offer Period for Intertrust Offer extended until 19 August 2022
Written by Customer Service on . Posted in Mergers And Acquisitions.
JOINT PRESS RELEASE
This is a joint press release by Intertrust N.V. (“Intertrust” or the “Company”) and CSC (Netherlands) Holdings B.V. (the “Offeror”), pursuant to the provisions of Section 15, paragraph 2 of the Netherlands Decree in Public Takeover Bids (Besluit openbare biedingen Wft, the “Decree”) in connection with the recommended public offer (the “Offer”) by the Offeror for all the issued and outstanding ordinary shares in the capital of Intertrust. This announcement does not constitute an offer, or any solicitation of any offer, to buy or subscribe for any securities in Intertrust. Any offer will be made only by means of an offer memorandum (the “Offer Memorandum”) approved by the Dutch Authority for Financial Markets (Stichting Autoriteit Financiële Markten, the “AFM”) which has been published on 31 March 2022, and subject to...
VELCAN HOLDINGS: CONVENING NOTICE OF THE ORDINARY ANNUAL GENERAL MEETING TO BE HELD ON 30th JUNE 2022
Written by Customer Service on . Posted in Public Companies.
PRESS RELEASE
Luxembourg, 30th May 2022
VELCAN HOLDINGS: CONVENING NOTICE OF THE ORDINARY ANNUAL GENERAL MEETING TO BE HELD ON 30thJUNE 2022
VELCAN HOLDINGS announces to the shareholders of the Company that the Ordinary Annual General Meeting will be held on Thursday the 30th of June 2022, at 3 p.m, in the offices of the law firm Tabery & Wauthier, 10 rue Pierre d’Aspelt, L‐1142 Luxembourg, in order to vote mainly on the approval of the 2021 condensed non-audited consolidated financial statements and of the 2021 audited statutory financial statements;
All required information and related documents will be available for downloading on the Company’s website on 30th May 2022:Convening notice of the Ordinary Annual General Meeting;
Board of Directors’ report on the resolutions proposed to the General Meeting;
Text of the proposed resolutions;
Single...
Kering: Press release – Disclosure of Transactions in Own Shares – May 23 to 27, 2022
Written by Customer Service on . Posted in Public Companies.
Paris, May 30, 2022,
Disclosure of Transactions in Own Shares
In accordance with the authorization given by the shareholders’ annual meeting on July 6, 2021 to trade on its own shares and pursuant to applicable law on share repurchase, Kering (LEI: 549300VGEJKB7SVUZR78) declares the following purchases of its own shares (FR0000121485) from May 23 to 27, 2022:
Issuer’s name
Issuer’s identifying code
Date of transaction
Identifying code of financial instrument
Aggregated daily volume (in number of shares)
Daily weighted average price of the purchased shares
Market
(MIC code)KERING
549300VGEJKB7SVUZR78
23/05/2022
FR0000121485
21 350
450.6116
XPARKERING
549300VGEJKB7SVUZR78
23/05/2022
FR0000121485
2 650
450.9472
CEUXKERING
549300VGEJKB7SVUZR78
24/05/2022
FR0000121485...
Aspo’s subsidiary Leipurin acquires Kobia AB and strengthens its position in the Western market in accordance with Aspo’s strategy
Written by Customer Service on . Posted in Mergers And Acquisitions.
Aspo PlcInside informationMay 30, 2022 at 17:35 p.m.
Aspo’s subsidiary Leipurin acquires Kobia AB and strengthens its position in the Western market in accordance with Aspo’s strategy
Aspo’s subsidiary Leipurin has agreed to purchase the entire share capital of the Swedish bakery industry distributor Kobia Ab from the Swedish Abdon Group. The acquisition will expand Leipurin’s geographical presence in the Northern European market. In 2021, Kobia’s net sales amounted to approximately EUR 50 million and its operating profit margin was approximately 3%. The transaction also includes the properties owned by Kobia, and the acquisition will not generate significant goodwill. The acquisition price is not disclosed.
Through the acquisition, Leipurin further strengthens its position as a leading player in the Baltic Sea region, with increased...
Irwin Naturals Files Q1 2022 Financials
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Cannabis Licensing and Ketamine ClinicRollup Strategy Accelerating Growth
Company to host conference call Tuesday, May 31, 2022 at 2:00 pm EST
LOS ANGELES, May 30, 2022 (GLOBE NEWSWIRE) — Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced the Company filed results for its first quarter of fiscal 2022, the period ended March 31, 2022 on www.sedar.com.
Philippe Faraut, CFO, stated, “Revenues were slightly impacted by supply chain issues related to a fire at a key supplier producing our CBD product line. These issues were resolved and, subsequent to the quarter, CBD sales are trending back to normal. Further impacts came from product transitions and order timing. Profitability remained strong with an 11.2% operating margin despite start-up expenses related to building our cannabis licensing...
The Harbourfront Group of Companies Reports First Quarter 2022 Financial Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
VANCOUVER, British Columbia, May 30, 2022 (GLOBE NEWSWIRE) — The Harbourfront Group of Companies (“The Harbourfront Group”), including Harbourfront Wealth Management Inc. (“Harbourfront” or “The Company”), today announced its results for the first quarter ended on March 31, 2022.
For the quarter, The Harbourfront Group reported a revenue increase of 11% year over year (YOY) to its board of directors.
Harbourfront continues to maintain a 100% advisor retention rate and onboarded new teams in the first quarter, resulting in a 40% YOY increase in assets under administration (AUA), bringing the company’s total AUA to over CAD $4 billion and assets under management (AUM) to over CAD $1.7 billion.
“Harbourfront is continuing its growth trajectory by attracting astute advisors who recognize the value of the unique product offerings available...
Inflammatory Bowel Disease Treatment Market Size [2022-2029]: $37.00 Billion by 2029 at CAGR of 5.7%
Written by Customer Service on . Posted in Mergers And Acquisitions.
According To Fortune Business Insights, The Global Inflammatory Bowel Disease Treatment Market Size Is Projected To Reach USD 37.00 Billion By 2028, Exhibiting A CAGR Of 5.5% During Forecast Period; Strong Focus on R&D for Treatment of Inflammatory Bowel Disease to Augment Market Growth
Pune, India, May 30, 2022 (GLOBE NEWSWIRE) — The global inflammatory bowel disease treatment market size was valued at USD 23.90 billion in 2021. The market is projected to grow from USD 25.18 billion in 2022 to USD 37.00 billion by 2029, exhibiting a CAGR of 5.7% during the forecast period. This information is published by Fortune Business Insights, in its report titled, “Inflammatory Bowel Disease Treatment Market, 2022-2029.”
The ulcerative colitis segment is anticipated to witness significant growth over the forecast period due to the high...
